Condition: Cannabis Use Disorder · Sponsor: Orygen
A randomized controlled trial to assess the efficacy of extended-release guanfacine to reduce cannabis use frequency in young people with cannabis use disorder following a period of monitored abstinence.
This description comes directly from the study's public registry record.
Gillinder Bedi, DPsych · +61 3 9966 9100 · gill.bedi@orygen.org.au
Emily A Karanges, PhD · emily.karanges@orygen.org.au
Always discuss trial participation with your own doctor first.
| Orygen | Parkville, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05957848